Amyloid a protein amyloidosis in a patient with plasma cell dyscrasia

Internal Medicine

Volumn 41, Issue 5, 2002, Pages 386-391

  Ishikawa, Hiroki ^a   Nakata, Keisuke ^a   Aritomi, Tomoyuki ^a   Ohkubo, Kazuaki ^a   Migita, Kiyoshi ^a   Hamasaki, Keisuke ^a   Yamasaki, Satoshi ^a   Nakao, Kazuhiko ^a   Kato, Yuji ^a   Hayashi, Tomayoshi ^b   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

HCV; PBMC; Serum AA

Indexed keywords

ALPHA INTERFERON; AMYLOID A PROTEIN; CONGO RED; DIAGNOSTIC AGENT; SERUM AMYLOID A;

ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPHAGIA; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN TISSUE; KIDNEY; LEG EDEMA; LIVER BIOPSY; MALE; MONONUCLEAR CELL; PLASMA CELL DYSCRASIA; PROTEIN DEGRADATION; PROTEINURIA; TONGUE; VOLUNTEER; IMMUNOELECTROPHORESIS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPROTEINEMIA; PATHOLOGY; STOMACH MUCOSA;

AMYLOIDOSIS; CONGO RED; GASTRIC MUCOSA; HEPATITIS C, CHRONIC; HUMANS; IMMUNOELECTROPHORESIS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARAPROTEINEMIAS; SERUM AMYLOID A PROTEIN;

EID: 0036019081     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.386     Document Type: Article

References (27)

1. Amyloid deposits and amyloidosis: The beta-fibrilloses (first of two parts)
2. Amyloid deposits and amyloidosis: The beta-fibrilloses (second of two parts)
3. Secondary systemic amyloidosis: Response and survival in 64 patients
4. The systemic amyloidoses
5. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases
6. Genetic abnormalities and pathogenesis of familial amyloidotic polyneuropathy
7. Familial amyloid polyneuropathy: New developments in genetics and treatment
8. Peripheral nerve amyloidosis
9. Serum amyloid A protein in amyloidosis, rheumatic, and neoplastic diseases
10. Amyloidosis: A familiar problem in the light of current pathogenetic developments
11. Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis
12. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes
13. Degradation of amyloid A precursor protein SAA by macrophage cell lines obtained from amyloid resistant and susceptible strains of mice
14. Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease
15. The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice
16. Secondary amyloidosis associated with Castleman's disease
17. Systemic reactive amyloidosis associated with Castleman's disease: Serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum
18. The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes
19. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: Evidence for a pathogenetic role
20. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma
21. Hepatitis C virus RNA in peripheral blood mononuclear cells: Comparing acute and chronic hepatitis C virus infection
22. Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients
23. Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis
24. P-component (pentagonal unit) of amyloid: Isolation, characterization, and sequence analysis
25. The P-component of amyloid of human islets of langerhans
26. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis
27. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid